Q32 Bio Inc. — Director's Dealing 2024

Mar 27, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Q32 Bio Inc. (FIXX)
CIK: 0001661998
Period of Report: 2024-03-25

Reporting Person: Alloway Paul (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-25	Common Stock	M	23530	—	Acquired	51566	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-25	Restricted Stock Units	$	M	5440	Disposed		Common Stock (5440)	Direct
2024-03-25	Restricted Stock Units	$	M	18090	Disposed		Common Stock (18090)	Direct

Footnotes

F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

F2: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.